Tramadol is a synthetic racemate: the (+) enantiomer is a prodrug of a weak opioid (CYP-2D6 converts tramadol to O -desmethyl tramadol - 'M1', the only active metabolite), while the (-) enantiomer increases synaptic noradrenaline and serotonin levels by inhibiting their reuptake and promoting release (through autoreceptor activation). Major effects are probably via modulation of descending pain pathways. Tramadol was synthesised in 1962, , and became available in Germany in 1977. Here, we look at its usage, pharmacokinetics, side-effects and merits. 1, low tylenol and hydrocodone. Usage The drug is an excellent agent for moderate to severe pain, in adults and children. Recommended dosage in adults parenterally (IM or slowly IV over 2-3min, or PCA) is a 100mg bolus, then 50mg every 10-20min, phentermine 375 mg overnight, with a maximum total dose 250mg; then 50-100mg 4-6 hourly to a maximum of 600mg/day, phentermine 375 mg overnight. Clearly adjust PCA appropriately, , perhaps 20mg boluses with 5 min lockout, phentermine 375 mg overnight. Per os, the adult dosage is 50 - 100 mg q 4-6hr as required, maximum 400mg/day. (For chronic pain, phentermine 375 mg overnight, fewer side-effects may be seen starting gradually, , with lower doses). In children, the dosage recommended is an initial 1-2mg/kg (Germany). Efficacy is excellent. Parenterally, phentermine 375 mg overnight, analgesic efficacy similar to that of morphine (or ketorolac), based on good visual analogue score (VAS) -based randomised, double blind, controlled studies in adults (with dose titration to response) summarised in Table V of Scott & Perry. In IV PCA studies, the drug is likewise similar to morphine (Scott & Perry, phentermine 375 mg overnight, Table VI). There is synergy with paracetamol, and non-steroidal anti-inflammatories. There seems to be no point in giving continuous infusions, phentermine 375 mg overnight, (30% more drug required), low tylenol and hydrocodone. Even this silliness appears not to be associated with more adverse events, phentermine 375 mg overnight. In children 1yr of age, but not in USA (< 16 yr age) or UK (< 12 yr), phentermine 375 mg overnight. Pharmacokinetics in children over 1 year of age appear similar to those in adults. 2. Pharmacokinetics Per os : peak effect after 1-4 hr, phentermine 375 mg overnight, lasts 3-6 hr; 68+% bioavailable; extensive first-pass activation and removal (by CYP, , including 3A4 - induced by carbamazepine). Parenterally : V D ~260L; Excretion of tramadol (and metabolites) is renal with a t 1/2 ß ~ 5.5 hr - for M1 the value is ~ 6.7+ hr. Plasma protein binding is 20%. Clearance is halved with liver or renal dysfunction. The drug is poorly dialysable. 3, phentermine 375 mg overnight. Side effects, interactions and cautions The major good point of tramadol is its minimal respiratory depression in therapeutic doses but you should exercise the usual caution you would with opiates. Interactions with with monoamine-oxidase inhibitors, alcohol (acute intoxication), hypnotics, centrally acting analgesics, opioids, and "psychotropics" (including selective serotonin reuptake inhibitors) preclude its use with such agents. It should also not be used in epileptic patients. Potential problems include CYP 2D6 deficiency, phentermine 375 mg overnight, which may have clinical consequences (about 30% of analgesia is from M1 metabolite); it may be more effective in extensive metabolisers (nobody appears to have looked at respiratory depression in this subgroup), phentermine 375 mg overnight! Interactions occur with carbamazepine or cimetidine (3A4 effect), and quinidine, fluoxetine or amitriptyline (2D6), but the clinical relevance of all of these is unclear. Interactions might possibly occur with coumarin anticoagulants (unlikely; this may be attributable to concomitant paracetamol administration)!! Watch for rare digoxin toxicity (??). Side Effects include nausea & vomiting (6% and ~2% respectively; more common with parenteral administration), dizziness, drowsiness, sweating. Nothing suggests a different tolerability profile in children, but this has not been extensively and specifically studied. Intra-operative awareness has been reported, but it would seem that the anaesthesia administered with the drug in these early reports was inadequate. Overdose is uncommon and abuse potential low . Features of overdose are what one would expect (sedation, nausea, vomiting) but importantly, phentermine 375 mg overnight, overdose may result in seizures. Seizures do not appear to occur with usual doses (in the absence of drug interactions or underlying epilepsy). Tramadol crosses the placenta , but appears safe in labour without neonatal respiratory depression. There is no evidence at present for teratogenicity, , but the usual cautions apply. A tiny amount enters breast milk (0.1%). Tramadol appears contra-indicated in porphyria. 4, low tylenol and hydrocodone. Benefits of Tramadol
It is an effective analgesic.
No significant respiratory depression occurs (in adults OR children) at recommended doses - IV /kg is similar to placebo; 1 or 2mg/kg caused substantially less respiratory depression in 88 children (2 - 10 yr) than did pethidine 1mg/kg - respiratory rate decreased by 7-12/min versus pethidine 31/min and placebo 2/min, with NO prolonged apnoea in the tramadol group. 90% of the pethidine group (versus 14 & 23% of the tramadol groups and 14% of placebo) needed manual ventilatory support. [Bosenberg AT & Ratcliffe S Anaesthesia 1998 Oct 53 960-4]
Tramadol appears to be antitussive, tramadol hci effects depression.
There is no clinically significant effect on heart rate or blood pressure have been recorded (adults or children). There is no relevant effect on GIT function (apart from the relatively infrequent side effects of nausea and occasional vomiting), tramadol 180 priority overnight.
Tramadol reduces post-operative shivering. (Interestingly, , the sweating threshold is decreased by tramadol, in contrast to other opioids; but like other opioids it lowers the vasoconstriction threshold and shivering threshold).
Clinical Trials Related to Tramadol A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAM® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral Surgery [Completed]
The purpose of this study is to explore the pain-relieving effects and safety of two analgesic treatment regimens as compared to placebo in patients experiencing pain after oral surgery. Tramadol hydrochloride/acetaminophen is approved to treat acute pain. This study will evaluate the effectiveness and safety of tramadol hydrochloride/acetaminophen compared with tramadol hydrochloride alone compared with placebo as a pain medication in the treatment of pain following oral surgery. CYTRAM (Cytochrome P450, Tramadol) [Recruiting]
Many methods to detect CYP2D6 poor metabolizers have been validated. Some of them are based on phenotyping (metabolism of dextromethorphan or debrisoquine) and some others on genotyping, tramadol 180 priority overnight. Up to now, phentermine 375 mg overnight, CYP2D6 pharmacogenetics has been restricted to the field of research, in spite of poor metabolizer profile concerns 5 to 10 % of caucasian population, phentermine 375 mg overnight. Nevertheless, , the polymorphism of CYP2D6 is responsible for the metabolism of many drugs, phentermine 375 mg overnight, particularly of two opioids involved in pain management: codeine and tramadol, phentermine 375 mg overnight, their metabolites representing the most effective part of the drug effect, tramadol hci effects depression. So prescribing codeine or tramadol in a patient poor metabolizer for the CYP2D6 is likely to be ineffective in pain management. O-demethyl-tramadol, the metabolite of tramadol via CYP2D6, is important to consider because its analgesic effect is 2 to 4 times more potent than tramadol. The investigators propose to phenotype CYP2D6 in post-operative patients treated by tramadol by monitoring seric concentrations of O-demethyl tramadol and tramadol to make a ratio in comparison with genotype, and to find a threshold to determine poor metabolizers. As already described, genotyping CYP2D6 will use a rapid detection method of the alleles implicated in poor metabolizer status (CYP2D6*3, *4, *5 et *6) in a Caucasian population. Sampling will be executed at two times (H24 and H48 after surgery) and only with blood (three EDTA tubes) during the post-operative monitoring of the patients. This study is likely to include 320 post-operative patients treated with intravenous tramadol during one year in three university hospitals centers (CHU of Caen, CrГ©teil and Rouen). The first aim of this study is the validation of monitoring seric concentrations of O-demethyl-tramadol and tramadol to make the ratio in order to detect CYP2D6 poor metabolizers in therapeutic situation, comparing the result with genotyping, phentermine 375 mg overnight. The finding of a poor metabolizer status in a patient will make the choice of analgesic drugs easier, avoiding tramadol and codeine. The final objective of this research is to be able to determine the CYP2D6 phenotype in a patient treated by tramadol without a good analgesia. By a single take of blood and a rapid response, this method should be liked to improve pain management. Furthermore, phentermine 375 mg overnight, CYP2D6 phenotyping is interesting for the patient because many other drugs depend on this way of metabolism. Comparison of Tramadol Orally Versus an Optimized Dose of Intravenous Tramadol for Postoperative Pain Relief in Ambulatory Surgery [Recruiting]
The purpose of this study is to compare the administration of 1 unit dose of 50 mg tramadol perorally given in 3 unit dosages versus tramadol IV given in 3 unit dosage of 35 mg during the first 6 hours postoperatively and to investigate the time course and accuracy of pain relief versus the onset and duration of side effects. The first unit dose will be administered at arrival at the PACU when a Visual Analogue Pain (VAS) score of more than 3 is reached, low tylenol and hydrocodone. The second and third unit dose will be administered after 1 and 2 hours, phentermine 375 mg overnight, respectively, , when a VAS of more than 3 is observed, phentermine 375 mg overnight. Efficacy, Safety, phentermine 375 mg overnight, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin [Recruiting]
Tramadol is an opioid analgesic, which is widely used in the treatment of acute and neuropathic pain. Treatment of neuropathic pain often requires a combination of pain medications due to the complex nature of neuropathic pain and frequent inadequate response to drug treatment, tramadol 180 priority overnight. Common drugs used concomitantly with tramadol are SNRI antidepressant duloxetine and anticonvulsants such as pregabalin. Both tramadol and duloxetine have serotonergic effects and duloxetine has also a potential to inhibit metabolism of tramadol, low tylenol and hydrocodone. The objective of the study is to investigate the pharmacokinetics and pharmacodynamic interaction of oral tramadol with duloxetine and pregabalin in patients with chronic neuropathic pain due to postherpetic neuralgia or diabetic polyneuropathy. All subjects will receive tramadol and duloxetine or tramadol and pregabalin in a randomized double-blind order. Primary end point is O-desmethyltramadol concentration. Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain. [Completed]
This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for patients with chronic low back pain, when administered over a 6-week period.
|
